Literature DB >> 10619738

Meningococcal pneumonia: characterization and review of cases seen over the past 25 years.

J M Winstead1, D S McKinsey, S Tasker, M A De Groote, L M Baddour.   

Abstract

Fifty-eight cases of meningococcal pneumonia were included in this review. Fifty cases previously described in the literature from 1974 through 1998 and 8 new cases were included in this series. The median age of patients was 57.5 years, and pleuritic chest pain was described in 21 (53.9%) of 39 cases. Blood cultures were positive in 42 (79.3%) of 53 cases for which results were mentioned. Despite the presence of bacteremia, patients did not develop the syndrome of meningococcemia with its associated complications. Serogroup Y meningococci were most commonly recovered and accounted for 44.2% of identified isolates. Therapy has dramatically changed over the past 25 years; prior to 1991, penicillin antibiotics were most often used. Since 1991, 12 (80%) of 15 patients received cephalosporin antibiotics. Only 5 (8.62%) of 58 patients died. Secondary cases of meningococcal infections following exposure to patients with meningococcal pneumonia were noted in 2 instances.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10619738     DOI: 10.1086/313617

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

1.  Gram-negative Diplococcal Respiratory Infections.

Authors:  Nargis Naheed; Maqsood Alam; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

2.  Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.

Authors:  Raymond S W Tsang; Averil M Henderson; Marissa L Cameron; Shaun D Tyler; Shari Tyson; Dennis K S Law; Jan Stoltz; Wendell D Zollinger
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 4.  A complicated simple fall--an atypical case of serogroup Y meningococcal pneumonia with secondary septicaemia and literature review.

Authors:  B K Y Chan; S Kudsk-Iversen; S Balaguruswamy; T S Purewal
Journal:  BMJ Case Rep       Date:  2012-04-04

5.  A Double Whammy Pneumonia: The First Reported Case of Concurrent Neisseria meningitidis and SARS-CoV-2 Pneumonia.

Authors:  Michael Valdez; Rupam Sharma; Jaspreet Joshi; Harleen Sandhu; Shikha Mishra; Rasha Kuran; Arash Heidari
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

Review 6.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.

Authors:  Muhamed-Kheir Taha; Catherine Weil-Olivier; Stéphane Bouée; Corinne Emery; Gaëlle Nachbaur; Céline Pribil; Véronique Loncle-Provot
Journal:  Hum Vaccin Immunother       Date:  2021-01-15       Impact factor: 3.452

8.  Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

Authors:  Shamez N Ladhani; Jay Lucidarme; Lynne S Newbold; Stephen J Gray; Anthony D Carr; Jamie Findlow; Mary E Ramsay; Edward B Kaczmarski; Raymond Borrow
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

9.  Bacteraemic pneumonia caused by Neisseria meningitidis serogroup Y.

Authors:  Maria Pilar Romero-Gomez; Zaida Rentero; Jose Ramon Paño; Jesus Mingorance
Journal:  Respir Med Case Rep       Date:  2011-12-26

Review 10.  Importance of circulating antibodies in protection against meningococcal disease.

Authors:  Kim S Erlich; Blaise L Congeni
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.